A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1168710
Abstract: Introduction Immunotherapy is an effective treatment for a subset of cancer patients, and expanding the benefits of immunotherapy to all cancer patients will require predictive biomarkers of response and immune-related adverse events (irAEs). To support… read more here.
Keywords: immunomodulatory proteins; immunotherapy clinical; studies immunotherapy; clinical trials ... See more keywords